InMode Ltd (INMD)
18.01
-0.99
(-5.21%)
USD |
NASDAQ |
Nov 15, 16:00
18.04
+0.03
(+0.17%)
After-Hours: 20:00
InMode Revenue (TTM): 423.75M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 423.75M |
June 30, 2024 | 416.63M |
March 31, 2024 | 466.26M |
December 31, 2023 | 492.05M |
September 30, 2023 | 498.84M |
June 30, 2023 | 496.96M |
March 31, 2023 | 474.42M |
December 31, 2022 | 454.27M |
September 30, 2022 | 431.24M |
June 30, 2022 | 404.18M |
March 31, 2022 | 377.96M |
December 31, 2021 | 357.56M |
Date | Value |
---|---|
September 30, 2021 | 322.21M |
June 30, 2021 | 287.75M |
March 31, 2021 | 231.19M |
December 31, 2020 | 206.11M |
September 30, 2020 | 177.92M |
June 30, 2020 | 158.22M |
March 31, 2020 | 166.25M |
December 31, 2019 | 156.36M |
September 30, 2019 | 138.14M |
June 30, 2019 | 123.55M |
March 31, 2019 | 109.80M |
December 31, 2018 | 100.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
156.36M
Minimum
Dec 2019
498.84M
Maximum
Sep 2023
350.01M
Average
391.07M
Median
Revenue (TTM) Benchmarks
Compugen Ltd | 59.85M |
Pluri Inc | 0.326M |
BioLine Rx Ltd | -- |
Can Fite Biofarma Ltd | 0.743M |
BiomX Inc | -- |